For most healthy individuals, infections are irritating, but not generally life-threatening, and many of them are successfully combated by the immune system alone. However, several infections require treatment. Some, but not all, of the potential future indications may provide great opportunities for DermaGen’s AMPs should proof of concept on appropriate peptides be successful.
We focus on diseases with a high medical need. The target disease spectrum includes common conditions such as, various types of infected skin eczema, atopic dermatitis, impetigo, infected skin wounds, various fungal infections, conjunctivitis, otitis externa, oral candidiasis, catheter-related infections and prophylaxis after skin surgery. Other indications are also possible in future development.